Silverarc Capital Management »

Moonlake Immunotherapeutics shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Moonlake Immunotherapeutics shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Moonlake Immunotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunotherapeutics held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunotherapeutics by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $466k 65k 7.17

More positions owned by Silverarc Capital Management

Abivax Sa Sponsored Ads (ABVX)
Rhythm Pharmaceuticals (RYTM)
Avidity Biosciences Ord (RNA)
Nuvalent Inc-a (NUVL)
Urogen Pharma (URGN)
Akero Therapeutics (AKRO)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Uniqure Nv SHS (QURE)
Cg Oncology (CGON)
United Therapeutics Corp Del Put Put Option
Oric Pharmaceuticals (ORIC)
Cidara Therapeutics Com New (CDTX)
Fractyl Health (GUTS)
Kalvista Pharmaceuticals (KALV)

View all positions for Silverarc Capital Management

Top funds holding Moonlake Immunotherapeutics

Simplex Trading
Group One Trading
Silverarc Capital Management
IMC-Chicago

View all funds holding Moonlake Immunotherapeutics